Wikidata

(Q61862145)

English

Phase 1 Dose Escalation and PK Study of Cu(II)ATSM in ALS/MND

clinical trial

In more languages

Statements

title
A Phase 1 Single and Multiple Dose Escalation and Pharmacokinetic Study of Cu(II)ATSM Administered Orally to Patients With Amyotrophic Lateral Sclerosis/Motor Neuron Disease (English)
0 references
country
Australia
0 references
start time
16 November 2016
0 references
end time
30 August 2019
0 references
number of participants
50
0 references
minimum age
18 year
0 references
maximum age
75 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q61862145&oldid=2104277745"